Understanding how ankyrin-1 affects red blood cell shape and stability
Architecture, dynamics and regulation of erythrocyte ankyrin-1 complexes
This study is looking at how a protein called ankyrin-1 helps keep red blood cells strong and healthy, which could help us understand certain inherited blood conditions like hereditary spherocytosis, and it’s for anyone interested in learning more about red blood cell disorders.
Quick facts
| Grant type | R01 grant |
|---|---|
| Study type | NIH-funded research |
| Funding institution | Columbia University Health Sciences NIH-funded |
| Lab location | 1 site (New York, United States) |
| Project ID | NIH-10909016 on NIH RePORTER |
What this research studies
This research investigates the role of ankyrin-1 in maintaining the structure and mechanical properties of red blood cells. By examining how ankyrin-1 clusters important membrane proteins and connects them to the cell's cytoskeleton, the study aims to uncover the mechanisms behind certain hereditary anemias, particularly hereditary spherocytosis. The researchers will utilize advanced techniques like cryoelectron microscopy to visualize these complexes in detail, which could lead to a better understanding of red blood cell disorders.
Who could benefit from this research
Good fit: Ideal candidates for this research are individuals diagnosed with hereditary anemias, especially those with hereditary spherocytosis.
Not a fit: Patients with non-hereditary forms of anemia or those without any erythrocyte membrane disorders may not benefit from this research.
Why it matters
Potential benefit: If successful, this research could lead to improved treatments for patients with hereditary anemias by providing insights into the underlying mechanisms of these conditions.
How similar studies have performed: While the specific mechanisms of ankyrin-1 have not been extensively studied, related research on membrane protein complexes has shown promise in understanding red blood cell disorders.
Where this research is happening
New York, United States
- Columbia University Health Sciences — New York, United States (Active)
Researchers
- Principal investigator: Clarke, Oliver Biggs — Columbia University Health Sciences
- Study coordinator: Clarke, Oliver Biggs
About this research
- This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
- Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
- For full project details, budget, and progress reports, visit the official NIH RePORTER page below.